A comprehensive analysis of 19 neurological conditions across 38 countries in the Americas reveals a paradox: between 1990 and 2023, the risk of dying from disorders such as stroke, Alzheimer’s and migraine has fallen, but the absolute number of people surviving—and living for longer with disability—has grown substantially. The study, led by the Pan American Health Organization and published in The Lancet Regional Health, found that in 2023 these conditions caused 1.1 million deaths but accounted for 37.5 million years of healthy life lost. Viewed from Washington, the trend signals that improved acute care and diagnosis have outpaced the ability of health systems to manage long-term consequences.

The drivers of this shift include population ageing and better survival after events like ischaemic stroke, yet new research also points to the role of chronic social stressors in accelerating brain decline. A British cohort study tracking 2,759 individuals from birth to age 71 found that persistent financial hardship in early and mid-adulthood was associated with worse cognitive performance by age 53 and poorer brain health on scans taken nearly two decades later. The association was more pronounced in men, those from disadvantaged childhoods, and carriers of a genetic variant linked to Alzheimer’s. In Argentina, where nearly half of adults report chronic stress—the highest self-reported rate globally, according to a clinical cardiologist in Buenos Aires—the physiological toll includes elevated cortisol, which damages arterial endothelia and can double the risk of myocardial infarction. Separately, researchers from UCL note that the constant cognitive load imposed by money worries may tax the brain’s attentional and decision-making bandwidth, compounding damage over decades.

National data underscore regional variations in the burden. In Colombia, migraine ranks as the neurological disorder that steals the most healthy years, followed by Alzheimer’s and other dementias, and then ischaemic stroke; the country records up to 60,000 new strokes annually. Across the Americas, tension-type headache, migraine, ADHD, ischaemic stroke, and Alzheimer’s are the most prevalent conditions. Public health officials in Bogotá and Santa Marta now promote the “CORRE+” mnemonic—facial droop, visual loss, rapid weakness, speech difficulty, equilibrium loss, emergency call—to shorten the time to treatment. The American Stroke Association encourages a similar “RAPIDO” checklist, stressing that clot-dissolving therapies must be given within 4.5 hours of symptom onset.

The study’s authors argue that health systems must pivot toward rehabilitation, long-term care, and social support. “Today more people survive neurological disorders, but they also live longer with their consequences,” said lead author Ramón Martínez. The findings land as households across high-income and middle-income countries face a sustained cost-of-living squeeze. For policymakers, the next milestone is whether budget allocations for rehabilitation and poverty reduction will keep pace with the epidemiological shift, or whether the rising disability curve will outstrip capacity.